Condition
Malaria Parasitaemia
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07548021Phase 1Not Yet Recruiting
Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda
NCT07094646Completed
Full Assessment of Clinical Transfusion Support
NCT00494416Not ApplicableCompletedPrimary
Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso
Showing all 3 trials